Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Compugen (CGEN) Research & Development (2016 - 2025)

Historic Research & Development for Compugen (CGEN) over the last 15 years, with Q3 2025 value amounting to $5.8 million.

  • Compugen's Research & Development fell 802.41% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year decrease of 2246.96%. This contributed to the annual value of $24.8 million for FY2024, which is 2802.85% down from last year.
  • Compugen's Research & Development amounted to $5.8 million in Q3 2025, which was down 802.41% from $5.6 million recorded in Q2 2025.
  • Compugen's 5-year Research & Development high stood at $10.9 million for Q4 2023, and its period low was $5.6 million during Q2 2025.
  • For the 5-year period, Compugen's Research & Development averaged around $7.2 million, with its median value being $7.2 million (2022).
  • Per our database at Business Quant, Compugen's Research & Development surged by 5863.32% in 2021 and then crashed by 4590.96% in 2024.
  • Over the past 5 years, Compugen's Research & Development (Quarter) stood at $8.7 million in 2021, then decreased by 16.05% to $7.3 million in 2022, then surged by 49.15% to $10.9 million in 2023, then plummeted by 45.91% to $5.9 million in 2024, then dropped by 1.88% to $5.8 million in 2025.
  • Its Research & Development stands at $5.8 million for Q3 2025, versus $5.6 million for Q2 2025 and $5.8 million for Q1 2025.